Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dario Health Corp
(NQ:
DRIO
)
0.9480
+0.1180 (+14.22%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dario Health Corp
< Previous
1
2
3
Next >
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
November 15, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Via
Benzinga
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
November 15, 2022
In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating.
Via
Talk Markets
DarioHealth: Q2 Earnings Insights
August 15, 2022
DarioHealth (NASDAQ:DRIO) reported its Q2 earnings results on Monday, August 15, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: DarioHealth Q1 Earnings
May 12, 2022
DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: DarioHealth Q4 Earnings
March 22, 2022
DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 20, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.
Via
Benzinga
US Stocks Open Higher Ahead Of Fed Decision, Dow Jumps 175 Points
September 21, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 175 points on Wednesday. The Federal Reserve will announce its policy decision at 2:00 p.m. ET. The country’s central bank is...
Via
Benzinga
Looking Into DarioHealth's Return On Capital Employed
September 09, 2022
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter.
Via
Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
August 24, 2022
DarioHealth Corp. (NASDAQ: DRIO) recently announced
Via
Benzinga
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
July 07, 2022
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and...
Via
Benzinga
DarioHealth Earnings Preview
March 18, 2022
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
DarioHealth Earnings Perspective: Return On Capital Employed
June 16, 2022
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million.
Via
Benzinga
Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET)
June 15, 2022
Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after...
Via
Benzinga
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know
May 16, 2022
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
May 13, 2022
Upgrades
Via
Benzinga
90 Biggest Movers From Yesterday
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)
May 11, 2022
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space...
Via
Benzinga
Earnings Outlook For DarioHealth
May 11, 2022
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth...
Via
Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
April 26, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a...
Via
Benzinga
DarioHealth's Return On Capital Employed Overview
March 23, 2022
According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 21, 2022
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
Via
Benzinga
Earnings Scheduled For March 21, 2022
March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 11, 2022
Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.
Via
Benzinga
DarioHealth Signs Multi-Year $30 Million-Dollar Deal With Sanofi U.S., Partnership To Increase Sales Reach In the Health Plan Market
March 01, 2022
Image sourced from Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. DarioHealth...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 01, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...
Via
Benzinga
DarioHealth Enters Into Strategic Agreement With Sanofi U.S.
March 01, 2022
Novel Strategic Agreement focuses on commercial growth for Dario and the development of Digital Health Solutions on Dario’s platform.
Via
Talk Markets
DarioHealth Expands Further Into Digital Musculoskeletal Market With PhysiMax Acquisition
February 09, 2022
Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
This AI-Driven, Hyper-Personalized App Wants To Be The SaaS Of Healthcare
February 02, 2022
Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Many software...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.